HomeeLibraryeLibrary resource

Hospital Level (Tertiary and Quaternary) - Medicine Reviews and Costing Reports - 2019 - 2021

Hospital Level (Tertiary and Quaternary) - Medicine Reviews and Costing Reports - 2019 - 2021

Hospital Level (Tertiary and Quaternary) - Medicine Reviews and Costing Reports - 2019 - 2021

Hospital Level (Tertiary and Quaternary) Medicine Reviews and Costing Documents 

 

 
All the Hospital Level – Tertiary and Quaternary (TQ) Medicine Recommendations, Medicine Reviews and Costing Reports from 2022 to date have been moved to the National Health Insurance webpage on the National Department of Health website. They can be accessed on the following link: https://www.health.gov.za/nhi-hpp-edp/
Type
Reports
Topic
Medicine Reviews and Costing Reports
Language
English
Publisher
National Department of Health
Copyright
Copyright Reserved
Year
2021
Download
CPA and MPA Reduce sexual drive Review N April 2019
Docetaxel CASTRATE RESISTANT Prostate cancer July 2019
Estrogen - Gender Dysphoria - Feminising N December 2019
Testosterone - Gender Dysphoria - Masculinising N December 2019
Asparaginase Historically Accepted Use N July 2019
Busulphan Historically Accepted Use N July 2019
Calcium folinate Historically Accepted Use July 2019
Chlorambucil Historically Accepted Use July 2019
Cisplatin METASTATIC Historically Accepted Use July 2019
Cisplatin radiosensitiser - Historically Accepted Use April 2019
Cytarabine injection Historically Accepted Use July 2019
Dacarbazine injection Historically Accepted Use July 2019
Daunorubicin injection Historically Accepted Use July 2019
Fludarabine injection Historically Accepted Use July 2019
Ifosfomide Historically Accepted Use July 2019
Melphalan Historically Accepted Use July 2019
Mercaptopurine Historically Accepted Use July 2019
Mesna Historically Accepted Use July 2019
IVIG for GBS Review December 2019
IVIG for Immune deficiencies-Review April 2019
Paclitaxel-cisplatin cervical Ca Summary July 2019
Paclitaxel-cisplatin_cervical Ca Review July 2019
Rituximab in lupus algorithm April 2019
Rituximab refractory LN Review April 2019
Thalidomide MM Review April 2019
Thalidomide MM Summary April 2019
Thalidomide Summary-ineligible April 2019
Trastuzumab 6 month course - N December 2019
Updated - Clinical criteria for access to Trastuzumab December 2019
Docetaxel-hormone sensitive prostate cancer January 2020
Gabapentin_pregabalin-neuralgia Review January 2020
5-FU actinic keratosis Historically Accepted Use March 2020
Indications_PN and micronutrients March 2020
Micronutrients - Annexure A N - March 2020
Micronutrients Summary N March 2020
Multiple Sclerosis agents Review March 2020
Bortezomib multiple myeloma Review March 2021
CEA of Bortezomib March 2021
Fulvestrant in breast Cancer review N March 2021
Review of Imiquimod for AGWS June 2021
Isotretinoin Access and Monioring June 2021
Isotretinoin Acne Review July 2021